Viewing StudyNCT00333229



Ignite Creation Date: 2024-05-05 @ 4:53 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00333229
Status: TERMINATED
Last Update Posted: 2014-11-25
First Post: 2006-05-31

Brief Title: A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women
Keywords:
Name View
Breast Cancer View
premenopausal View
Bone Mineral density View
Cancer therapy induced bone loss View
zoledronic acid View